First patients in NIH ACTIV-3 clinical trial enroll in Dallas 0 08.08.2020 07:00 Eurekalert.org (Baylor Scott & White Research Institute) Baylor Scott & White Research Institute becomes first site in the world to conduct new trial testing experimental monoclonal antibodies as a treatment for hospitalized COVID-19 patients Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
